GENRX LINEZOLID linezolid 600 mg tablet blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

linezolid, Quantity: 600 mg

Dostępny od:

Arrotex Pharmaceuticals Pty Ltd

INN (International Nazwa):

Linezolid

Forma farmaceutyczna:

Tablet, film coated

Skład:

Excipient Ingredients: magnesium stearate; hypromellose; macrogol 8000; crospovidone; methylcellulose; titanium dioxide; hyprolose; silicon dioxide

Droga podania:

Oral

Sztuk w opakowaniu:

10

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Linezolid (intravenous or oral) is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species. It is active against Gram-positive bacteria only and has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Podsumowanie produktu:

Visual Identification: White coloured, oval shaped, biconvex, film-coated tablet with "APO" engraved on one side and "LIN600" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Licence status A

Data autoryzacji:

2014-01-31